Trial · NCT04027348
Adverse events30
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
1 to 20 of 30
Download this page as JSON| Type | Event | Organ system | Group | Affected | At risk | Events |
|---|---|---|---|---|---|---|
| other | Sinus bradycardia | Cardiac disorders | Treatment (Octreotide, Dexamethasone, Metoclopramide) | 2 | 15 | 2 |
| other | Abdominal pain | Gastrointestinal disorders | Treatment (Octreotide, Dexamethasone, Metoclopramide) | 1 | 15 | 1 |
| other | Diarrhea | Gastrointestinal disorders | Treatment (Octreotide, Dexamethasone, Metoclopramide) | 2 | 15 | 2 |
| other | Dry mouth | Gastrointestinal disorders | Treatment (Octreotide, Dexamethasone, Metoclopramide) | 1 | 15 | 1 |
| other | Nausea | Gastrointestinal disorders | Treatment (Octreotide, Dexamethasone, Metoclopramide) | 2 | 15 | 2 |
| other | Small intestinal obstruction | Gastrointestinal disorders | Treatment (Octreotide, Dexamethasone, Metoclopramide) | 5 | 15 | 6 |
| other | Vomiting | Gastrointestinal disorders | Treatment (Octreotide, Dexamethasone, Metoclopramide) | 2 | 15 | 2 |
| other | Edema limbs | General disorders | Treatment (Octreotide, Dexamethasone, Metoclopramide) | 3 | 15 | 3 |
| other | Fatigue | General disorders | Treatment (Octreotide, Dexamethasone, Metoclopramide) | 1 | 15 | 1 |
| other | Pain | General disorders | Treatment (Octreotide, Dexamethasone, Metoclopramide) | 2 | 15 | 2 |
| other | Sepsis | Infections and infestations | Treatment (Octreotide, Dexamethasone, Metoclopramide) | 2 | 15 | 2 |
| other | Thrush | Infections and infestations | Treatment (Octreotide, Dexamethasone, Metoclopramide) | 1 | 15 | 1 |
| other | Neutrophil count decreased | Investigations | Treatment (Octreotide, Dexamethasone, Metoclopramide) | 1 | 15 | 1 |
| other | Anorexia | Metabolism and nutrition disorders | Treatment (Octreotide, Dexamethasone, Metoclopramide) | 4 | 15 | 4 |
| other | Peripheral sensory neuropathy | Nervous system disorders | Treatment (Octreotide, Dexamethasone, Metoclopramide) | 1 | 15 | 1 |
| other | Syncope | Nervous system disorders | Treatment (Octreotide, Dexamethasone, Metoclopramide) | 1 | 15 | 1 |
| other | Anxiety | Psychiatric disorders | Treatment (Octreotide, Dexamethasone, Metoclopramide) | 1 | 15 | 1 |
| other | Insomnia | Psychiatric disorders | Treatment (Octreotide, Dexamethasone, Metoclopramide) | 3 | 15 | 3 |
| other | Hypoxia | Respiratory, thoracic and mediastinal disorders | Treatment (Octreotide, Dexamethasone, Metoclopramide) | 1 | 15 | 1 |
| other | Hypertension | Vascular disorders | Treatment (Octreotide, Dexamethasone, Metoclopramide) | 1 | 15 | 1 |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT04027348/events